{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:54:12Z","timestamp":1794020052952,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymgme.2025.109709","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T23:35:55Z","timestamp":1767224155000},"page":"109709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis, treatment, and follow-up of Fabry disease in pediatrics"],"prefix":"10.1016","volume":"147","author":[{"given":"Juan Guillermo","family":"C\u00e1rdenas-Aguilera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Roc\u00edo","family":"Chac\u00f3n-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Zarante-Baham\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Katherina","family":"Serrano-Gayubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Prieto-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Isabel","family":"Meza-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Armando","family":"Rojas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena Adriana","family":"C\u00e1ceres-Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryuri Liseth","family":"Duarte-Amorocho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Milena","family":"P\u00e9rez-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00edmaco Andr\u00e9s","family":"Jim\u00e9nez-Triana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Baquero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Ximena","family":"Fl\u00f3rez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fernanda","family":"Reina-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Adolfo","family":"Guerrero-Tinoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Guarnizo-Zuccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazm\u00edn","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"V\u00e9lez-Echeverry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Mar\u00eda","family":"Rubio-Elorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"del Roci\u00f3 Mera-Solarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Isabel","family":"Carrascal-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pahola Shirley Atehort\u00faa","family":"Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Rozo-Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Olivas-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Trimarchi-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Canal-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Marques-Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Reyes-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Belmont-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Horacio","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Politei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Bernardo","family":"Ripeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Javier","family":"Perretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ymgme.2025.109709_bb0005","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.3390\/ijms221810088","article-title":"Pathogenesis and molecular mechanisms of anderson\u2013fabry disease and possible new molecular addressed therapeutic strategies","volume":"22","author":"Tuttolomondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"71","key":"10.1016\/j.ymgme.2025.109709_bb0010","article-title":"Fabry Disease - literature review","author":"Wdowiak","year":"2024","journal-title":"J. Educat. Health and Sport [Internet]."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109709_bb0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2169\/internalmedicine.2493-23","article-title":"Profiles of Globotriaosylsphingosine analogs and Globotriaosylceramide isoforms accumulated in body fluids from various phenotypic Fabry Patients","volume":"63","author":"Shiga","year":"2024","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/genes15010037","article-title":"Fabry disease in women: genetic basis, available biomarkers, and clinical manifestations","volume":"15","author":"Izhar","year":"2024","journal-title":"Genes (Basel)"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109709_bb0025","article-title":"Clinical characteristics, renal involvement, and therapeutic options of pediatric Patients with Fabry Disease","author":"Muntean","year":"2022","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109709_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2021.12.004","article-title":"Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression","volume":"135","author":"Van der Veen","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109709_bb0035","article-title":"Expert consensus on evidence-based recommendations for the diagnosis, treatment, and follow-up of fabry disease in pediatric patients","volume":"21","author":"Rodr\u00edguez","year":"2023","journal-title":"Revista Ciencias de la Salud"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.aprim.2013.12.013","article-title":"Sistema GRADE: Metodolog\u00eda Para la realizaci\u00f3n de recomendaciones Para la pr\u00e1ctica cl\u00ednica","volume":"47","author":"Sanabria","year":"2015","journal-title":"Aten. Primaria"},{"key":"10.1016\/j.ymgme.2025.109709_bb0045","doi-asserted-by":"crossref","first-page":"101891","DOI":"10.1016\/j.gimo.2024.101891","article-title":"Prospective characterization of Early symptom onset and progression in young pediatric Patients with Variants in the GLA gene across five years: longitudinal data from the Fabry MOPPet study","volume":"2","author":"Laney","year":"2024","journal-title":"Genet. Med. Open."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12882-023-03138-w","article-title":"The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages","volume":"24","author":"Guo","year":"2023","journal-title":"BMC Nephrol."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109709_bb0055","article-title":"Clinical features and enzyme replacement therapy in 10 children with Fabry disease","author":"Li","year":"2023","journal-title":"Front. Pediatr."},{"issue":"26","key":"10.1016\/j.ymgme.2025.109709_bb0060","article-title":"Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy","author":"Dutra-Clarke","year":"2021","journal-title":"Mol Genet Metab Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13730-020-00527-0","article-title":"A classic variant of Fabry disease in a family with the M296I late-onset variant","volume":"10","author":"Hirashio","year":"2021","journal-title":"CEN Case Rep."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109709_bb0070","article-title":"Cases of Fabry disease in which pathogenic variants are not detected in parent-child pairs","volume":"16","author":"Akeho","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13023-022-02417-3","article-title":"Burden associated with Fabry disease and its treatment in 12\u201315 year olds: results from a European survey","volume":"17","author":"Bashorum","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"15","key":"10.1016\/j.ymgme.2025.109709_bb0080","first-page":"1","article-title":"Retrospective evaluation of Clinical and molecular characteristics of Patients with Fabry Disease being followed-up in our clinic","author":"Kasapkara","year":"2021","journal-title":"Turkish J. Pediatric Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109709_bb0085","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/13816810.2022.2132515","article-title":"Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease","volume":"43","author":"Nilsson","year":"2022","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2025.109709_bb0090","article-title":"Depression: the hidden problem in Fabry Disease","volume":"9","author":"Chertcoff","year":"2021","journal-title":"J Inborn Errors Metab Screen [Internet]."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.15403\/jgld-3855","article-title":"Gastrointestinal manifestations and treatment options in fabry disease patients. a systematic review","volume":"31","author":"Radulescu","year":"2022","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"13","key":"10.1016\/j.ymgme.2025.109709_bb0100","article-title":"Neuropsychiatric symptoms and their association with sex, age, and enzyme replacement therapy in Fabry Disease: a systematic review","volume":"16","author":"Mroczek","year":"2022","journal-title":"Front Psychiatry."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-022-02215-x","article-title":"Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective","volume":"17","author":"Ezgu","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109709_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246682","article-title":"Early renal failure in childhood in a male with Fabry disease","volume":"15","author":"Hogh","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109709_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/diagnostics14020208","article-title":"Anderson\u2013Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement","volume":"14","author":"Iorio","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13023-023-02806-2","article-title":"Low skeletal muscle mass as an early sign in children with fabry disease","volume":"18","author":"Lu","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109709_bb0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/2175-8239-jbn-2021-0216","article-title":"Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare diseases Committee of the Brazilian Society of nephrology (Comdora-SBN)","volume":"44","author":"Mhelena","year":"2022","journal-title":"Brazilian J. Nephrol. [Internet]."},{"issue":"31","key":"10.1016\/j.ymgme.2025.109709_bb0130","article-title":"Translation of quality of life scale for pediatric patients with Fabry disease in Japan","author":"Koto","year":"2022","journal-title":"Mol Genet Metab Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109709_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns9020031","article-title":"Newborn screening for fabry disease: current status of knowledge","volume":"9","author":"Gragnaniello","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109709_bb0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/biom11070951","article-title":"Newborn screening for fabry disease in northeastern italy: results of five years of experience","volume":"11","author":"Gragnaniello","year":"2021","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109709_bb0145","doi-asserted-by":"crossref","first-page":"1057014","DOI":"10.3389\/fped.2023.1057014","article-title":"Clinical evaluation, accurate diagnosis and treatment of four pedigrees with Fabry\u2019s disease","volume":"15","author":"Gou","year":"2023","journal-title":"Front. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109709_bb0150","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1515\/cclm-2021-0316","article-title":"Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients","volume":"59","author":"Malvagia","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109709_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109709_bb0160","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/genes14112016","article-title":"Genotype\u2013phenotype correlations in 293 Russian Patients with Causal Fabry Disease Variants","volume":"14","author":"Savostyanov","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-02136-1","article-title":"Multidisciplinary approach to screening and management of children with Fabry disease: practice at a tertiary children\u2019s Hospital in China","volume":"16","author":"Shen","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109709_bb0170","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/genes13091619","article-title":"The benefits of family screening in rare diseases: genetic testing reveals 165 new cases of fabry disease among at-risk family members of 83 index patients","volume":"13","author":"Moiseev","year":"2022","journal-title":"Genes (Basel)"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109709_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63552","article-title":"Experience with cascade screening: A comprehensive family pedigree analysis of two index patients with Fabry disease","volume":"194","author":"Kisa","year":"2024","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109709_bb0180","article-title":"Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies","volume":"16","author":"Monda","year":"2023","journal-title":"Circ Genom Precis Med."},{"issue":"16","key":"10.1016\/j.ymgme.2025.109709_bb0185","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/jcm10163543","article-title":"Detailed phenotype of GLA variants identified by the nationwide neurological screening of stroke patients in the Czech Republic","volume":"10","author":"Rekov\u00e1","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109709_bb0190","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12020-021-02918-4","article-title":"Endocrine disorders in patients with Fabry disease: insights from a reference centre prospective study","volume":"75","author":"Bothou","year":"2022","journal-title":"Endocrine"},{"issue":"38","key":"10.1016\/j.ymgme.2025.109709_bb0195","article-title":"Use of T1 mapping in cardiac MRI for the follow-up of Fabry disease in a pediatric population","author":"Werner","year":"2024","journal-title":"Mol Genet Metab Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-024-03131-y","article-title":"A systematic literature review on the health-related quality of life and economic burden of Fabry disease","volume":"19","author":"Jovanovic","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","article-title":"Twenty years of the Fabry outcome survey (FOS): insights, achievements, and lessons learned from a global patient registry","volume":"17","author":"Beck","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-023-06050-5","article-title":"Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease","volume":"39","author":"Avarappattu","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2025.109709_bb0215","series-title":"Acta No 05. Comisi\u00f3n revisora sala especializada de mol\u00e9culas nuevas","first-page":"1","author":"INVIMA","year":"2023"},{"key":"10.1016\/j.ymgme.2025.109709_bb0220","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Cerezo JF, Fern\u00e1ndez-Mart\u00edn J, Barba-Romero M\u00c1, S\u00e1nchez-Mart\u00ednez R, Hermida-Ameijeiras A, Camprodon-G\u00f3mez M, et al. Current status of the immunogenicity of enzyme replacement therapy in fabry disease. Orphanet J. Rare Dis., 20(1), 253. Available from: doi: https:\/\/doi.org\/10.1186\/s13023-025-03705-4.","DOI":"10.1186\/s13023-025-03705-4"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109709_bb0225","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s13346-024-01583-0","article-title":"Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review","volume":"14","author":"Rodr\u00edguez-Castej\u00f3n","year":"2024","journal-title":"Drug Deliv Transl. Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109709_bb0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2021.07.006","article-title":"Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing","volume":"134","author":"Domm","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109709_bb0235","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2147\/DDDT.S313789","article-title":"Prompt agalsidase alfa therapy initiation is associated with improved renal and cardiovascular outcomes in a fabry outcome survey analysis","volume":"15","author":"Hughes","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109709_bb0240","doi-asserted-by":"crossref","first-page":"106967","DOI":"10.1016\/j.ymgme.2022.106967","article-title":"Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry","volume":"138","author":"Hopkin","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109709_bb0245","first-page":"3","article-title":"Recommendations for the diagnosis, treatment, and follow-up of Fabry Disease in Argentina 2025","volume":"23","author":"Perretta","year":"2025","journal-title":"Nefrolog\u00eda Argentina."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109709_bb0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109709_bb0255","article-title":"Potential usefulness of lifetime globotriaosylsphingosine exposure at diagnosis and baseline modified disease severity score in early-diagnosed patients with fabry disease","volume":"16","author":"Hotta","year":"2024","journal-title":"Cureus"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225007012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225007012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:10:20Z","timestamp":1777608620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225007012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1096719225007012"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109709","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis, treatment, and follow-up of Fabry disease in pediatrics","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109709"}}